Economic Analysis of Anti-Rheumatic Medication in an Observational Cohort of Ontario Rheumatoid Arthritis Patients: Coverage with Evidence Development from the Ontario Best Practices Research Initiative

安大略省类风湿关节炎患者观察队列中抗风湿药物的经济分析：安大略省最佳实践研究计划证据开发的覆盖范围

• 批准号: 311841
• 负责人: Tatangelo Mark R
• 金额: $ 1.27万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-12-01 至 2014-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=311841&lang=en
• 关键词: Chronic Diseases; Coverage With Evidence Development; Economic Analysis; Economic Models; Health Care Resource Utilization; Health Services Research; Observational Cohort; Population Health; Rheumatoid Arthritis

Biologic therapies are an expensive treatment for rheumatoid arthritis. Payers of rheumatoid arthritis medication cost including government, and private insurers make decisions on which drugs to pay for based on economic analysis to determine which drugs

生物疗法是治疗类风湿性关节炎的昂贵方法。类风湿性关节炎药物费用的支付者包括政府和私人保险公司，他们根据经济分析来决定支付哪些药物